David James Lennon, CHIEF EXECUTIVE OFFICER at Whitehawk Therapeutics, Inc. (WHWK), sold 26,858 shares at $3.48 ($93K) on 2026-04-02, disclosed to the SEC on 2026-04-03.
Open-market sale of $93k WHWK by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| WHWK | SELL | 2026-03-10 | $17K | — | Filing → |
| AADI | SELL | 2025-03-03 | $13K | — | Filing → |
| AADI | SELL | 2024-10-03 | $19K | — | Filing → |